Alembic plans rights issue to fund expansionIllustrative image – not actual.

Alembic Ltd is planning a rights issue to fund its various expansion schemes, cumulatively estimated to entail an investment of Rs.65 crore.

 

The schemes are to be implemented in 2 phases over the next 2 years.  The existing unit at Vadodara is to be put through an upgradation progamme. The company intends to seek approvals from the drug administrations of USA, UK and South Africa for the Vadodara unit. A new formulations plant is also planned in Himachal Pradesh.

 

The proposed rights issue will be considered at the meeting of the company’s board on 1 September 2003.

← All latest storiesBack to top →